Bimetallic MnZnS X Nanotheranostics for Self‐Activatable Chemo‐Immunotherapy of Hepatocellular Carcinoma via H₂S‐Triggered Arsenic Prodrug Activation and Binary cGAS‐STING Pathway Modulation
Advanced Healthcare Materials · 2025
DOI: 10.1002/adhm.202404238 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Healthcare Materials, 2025. Verfasst von WeiYi Cheng und 9 weiteren Autor:innen. Beteiligte Einrichtung: School of Pharmaceutical Sciences, Zhejiang Chinese Medical University, Hangzhou, 310053, China. Hauptthemen laut MEDLINE: Prodrugs, Carcinoma, Hepatocellular, Liver Neoplasms, Membrane Proteins. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 45 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Natural Science Foundation of Zhejiang Province, Natural Science Foundation of Hangzhou under Grant.
Abstract (Originalsprache)
Arsenic trioxide (As 2 O 3 ) has long been utilized in traditional Chinese medicine due to its therapeutic properties. While it exhibits potent anticancer activity, its clinical application is hindered by systemic toxicity and limited tissue specificity. In this study, an advanced therapeutic approach is developed using arsenic prodrug‐loaded bimetallic sulfide MnZnS X nanorods (As‐MnZnS X NRs) to enhance both the efficacy and safety of As 2 O 3 in hepatocellular carcinoma treatment. These nanorods are engineered to release Mn 2+ and H 2 S within the tumor microenvironment, facilitating binary‐cooperative activation of the cGAS‐STING pathway. This dual activation mechanism enhances immune responses while converting the arsenic prodrug into its cytotoxic form, As III . The results demonstrate that Mn 2+ amplifies the cGAS‐STING pathway by inducing TBK1 phosphorylation and IRF3 activation, leading to dendritic cell maturation and improved tumor antigen cross‐presentation. Simultaneously, H 2 S promotes prodrug conversion and enhances immune activation, collectively driving binary stimulation of the cGAS‐STING pathway. This strategy significantly augments the antitumor efficacy of As 2 O 3 by integrating immune modulation with targeted cytotoxic effects. Furthermore, MnZnS X nanorods enable in vivo MRI, allowing real‐time monitoring of treatment progression. This study represents a substantial advancement in liver cancer therapy by integrating chemoimmunotherapy with diagnostic imaging, thereby improving therapeutic precision while minimizing systemic toxicity.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Pharmaceutical Sciences, Zhejiang Chinese Medical University, Hangzhou, 310053, China.
- State Key Laboratory of Infectious Disease Vaccine Development, Xiang'an Biomedicine Laboratory, National Innovation Platform for Industry-Education Integration in Vaccine Research, Center for Molecular Imaging and Tran…
- Department of Dermatology & Cosmetology, The First Affiliated Hospital of Zhejiang Chinese Medical University (Zhejiang Provincial Hospital of Traditional Chinese Medicine), Hangzhou, 310006, China.
ORCID-Profile: Ji-Gang Piao
Förderung
- National Natural Science Foundation of China
- Natural Science Foundation of Zhejiang Province
- Natural Science Foundation of Hangzhou under Grant
- Research Project of Zhejiang Chinese Medical University
Zitieren
APA
Cheng, W., Peng, X., He, L., Ren, W., Chen, J., Tang, X., Bao, D., Liu, G., Jiang, L., & Piao, J. G. (2025). Bimetallic MnZnS X Nanotheranostics for Self‐Activatable Chemo‐Immunotherapy of Hepatocellular Carcinoma via H₂S‐Triggered Arsenic Prodrug Activation and Binary cGAS‐STING Pathway Modulation. Advanced Healthcare Materials. https://doi.org/10.1002/adhm.202404238
Vancouver
Cheng W, Peng X, He L, Ren W, Chen J, Tang X, et al. Bimetallic MnZnS X Nanotheranostics for Self‐Activatable Chemo‐Immunotherapy of Hepatocellular Carcinoma via H₂S‐Triggered Arsenic Prodrug Activation and Binary cGAS‐STING Pathway Modulation. Advanced Healthcare Materials. 2025. doi:10.1002/adhm.202404238
BibTeX
@article{Cheng2025,
author = {Cheng, WeiYi and Peng, Xuqi and He, Li and Ren, WeiYe and Chen, JingQuan and Tang, XiaoQian and Bao, Dandan and Liu, Gang and Jiang, Lai and Piao, Ji-Gang},
title = {Bimetallic MnZnS X Nanotheranostics for Self‐Activatable Chemo‐Immunotherapy of Hepatocellular Carcinoma via H₂S‐Triggered Arsenic Prodrug Activation and Binary cGAS‐STING Pathway Modulation},
journal = {Advanced Healthcare Materials},
year = {2025},
doi = {10.1002/adhm.202404238}
}
EUVIMED